Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas [NA]

View source ↗

Summary

This trial update describes evaluating Embella, a deoxycholic acid injection from Espad Pharmed, for managing superficial lipomas, with the study currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Embella (Deoxycholic acid)

Snippet

Sponsor: Espad Pharmed | Conditions: Lipoma | NA | Status: RECRUITING